Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
SIRT3 encodes a member of the sirtuin family of proteins, homologs to the yeast Sir2 protein. Additionally we are shipping SIRT3 Kits (22) and SIRT3 Proteins (15) and many more products for this protein.
Showing 10 out of 235 products:
Human Polyclonal SIRT3 Primary Antibody for IHC (p), WB - ABIN390178
Pillai, Sundaresan, Kim, Gupta, Rajamohan, Pillai, Samant, Ravindra, Isbatan, Gupta: Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. in The Journal of biological chemistry 2010
Show all 11 Pubmed References
Cow (Bovine) Polyclonal SIRT3 Primary Antibody for IHC, WB - ABIN2779610
Onyango, Celic, McCaffery, Boeke, Feinberg: SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. in Proceedings of the National Academy of Sciences of the United States of America 2002
Show all 4 Pubmed References
Hamster Polyclonal SIRT3 Primary Antibody for IHC (p), WB - ABIN652184
Kawamura, Uchijima, Horike, Tonami, Nishiyama, Amano, Asano, Kurihara, Kurihara: Sirt3 protects in vitro-fertilized mouse preimplantation embryos against oxidative stress-induced p53-mediated developmental arrest. in The Journal of clinical investigation 2010
Show all 2 Pubmed References
Human Polyclonal SIRT3 Primary Antibody for ELISA, WB - ABIN269822
Shi, Wang, Stieren, Tong: SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. in The Journal of biological chemistry 2005
Show all 2 Pubmed References
survival curves showed that higher SIRT3 expression is correlated to a poorer prognosis for patients with grade 3 breast cancer. In conclusion, SIRT3 could be a therapeutic target for breast cancer, improving the effectiveness of CDDP and TAM (show CCNA1 Antibodies) treatments.
There were no significant correlations between LRP130 (show LRPPRC Antibodies), SIRT3, or PGC-1alpha (show PPARGC1A Antibodies) mRNA expression in response to acute sprint-interval training. Changes in protein expression of LRP130 (show LRPPRC Antibodies), SIRT3, and PGC-1alpha (show PPARGC1A Antibodies) were positively correlated at several time points with large effect sizes, which suggest that the regulation of these proteins may be coordinated in human skeletal muscle.
In human myometrium, SIRT3 expression decreases with term labor and regulates the mediators involved in the terminal effector pathways of human labor and delivery through the NFkappaB1 pathway.
Mitochondria-targeted esculetin has anti-atherosclerotic effects by inhibiting PAI-1 (show SERPINE1 Antibodies) levels by modulating miR (show MLXIP Antibodies)-19b and -30c expression and affecting SIRT3- and STAT3 (show STAT3 Antibodies)-mediated signaling pathways.
the activation of the SIRT3 axis of the UPRmt is linked to metastasis.
these results suggest a potential relationship between SIRT3 enzymatic activity, IDH2 (show IDH2 Antibodies)-K413 acetylation-determined dimerization, and a cancer-permissive phenotype
These data suggest a novel role for SIRT3 deficiency in mediating alveolar epithelial cell mtDNA damage, apoptosis, and lung fibrosis.-
Data suggested a protective role of the SIRT3 single-nucleotide polymorphism rs4980329 in ALS risk.
Low SIRT3 expression is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
Low SIRT3 expression is associated with Prostate Cancer.
Sirtuin 3 is required for osteogenic differentiation through maintenance of PGC (show PGC Antibodies)-1a-SOD2 (show SOD2 Antibodies)-mediated regulation of mitochondrial function
findings reveal an unexpected mechanism for SIRT3 regulation via SIRT1 (show SIRT1 Antibodies)-mediated deacetylation. Improving mitochondrial SIRT3 functions by inhibiting SIRT3 acetylation may offer a new therapeutic approach for obesity- and aging-related diseases associated with mitochondrial dysfunction.
Sirt3 expression in bone marrow cells increases during aging, suggesting that Sirt3 promotes age-related adipogenesis and osteoclastogenesis associated with bone loss. These findings identify Sirt3 as an important regulator of adipogenesis and skeletal homeostasis in vivo and identify Sirt3 as a potential target for the treatment of osteoporosis.
Diminished Sirt3 expression and redox inactivation of Sirt3 led to SOD2 (show SOD2 Antibodies) inactivation and contributes to hypertension.
Data suggest that negative regulatory effect of Sirt3 on Nlrp3 (show NLRP3 Antibodies) inflammasome assembly in macrophages due to prolonged fasting occurs via Sirt3-mediated deacetylation of mitochondrial Sod2 (show SOD2 Antibodies), leading to Sod2 (show SOD2 Antibodies) activation; prolonged fasting blunts inflammasomes in wild-type mice but not in Sirt3 knock-out mice. (Sirt3 = sirtuin 3; Nlrp3 (show NLRP3 Antibodies) = NLR (show CXCR5 Antibodies) family, pyrin domain containing 3 protein; Sod2 (show SOD2 Antibodies) = superoxide dismutase 2 (show SOD2 Antibodies))
Results reveal a potential mechanism by which SIRT3 deletion exacerbates post-MI cardiac dysfunction and impairment of cardiac recovery involving microvascular rarefaction and pre-existing coronary microvascular dysfunction.
expression and activity of the NADase CD38 increase with aging and that CD38 is required for the age-related NAD decline and mitochondrial dysfunction via a pathway mediated at least in part by regulation of SIRT3 activity.
Data show that resveratrol reduced mitochondrial reactive oxygen species (mROS) generation by promoting Sirt3 enrichment within the mitochondria and subsequent upregulation of FoxO3a (show FOXO3 Antibodies)-mediated mitochondria gene expression of PGC-1alpha (show PPARGC1A Antibodies) and SOD2 (show SOD2 Antibodies).
These data demonstrate a critical role of SIRT3 in the control of myofibroblast differentiation and lung fibrosis.
The results indicate that the variations in the class I sirtuin (show SIRT1 Antibodies) genes and their corresponding genotypes may be considered as molecular markers for economic traits in cattle breeding.
The expression profile of sirtuin 1 (show SIRT1 Antibodies) and sirtuin 3 in the liver, muscle, and adipose tissue of calves and bulls is reported.
This gene encodes a member of the sirtuin family of proteins, homologs to the yeast Sir2 protein. Members of the sirtuin family are characterized by a sirtuin core domain and grouped into four classes. The functions of human sirtuins have not yet been determined\; however, yeast sirtuin proteins are known to regulate epigenetic gene silencing and suppress recombination of rDNA. Studies suggest that the human sirtuins may function as intracellular regulatory proteins with mono-ADP-ribosyltransferase activity. The protein encoded by this gene is included in class I of the sirtuin family. Two alternatively spliced transcript variants that encode different proteins have been described for this gene.
, NAD-dependent deacetylase sirtuin-3, mitochondrial
, NAD-dependent protein deacetylase sirtuin-3, mitochondrial
, SIR2-like protein 3
, mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase
, regulatory protein SIR2 homolog 3
, silent mating type information regulation 2, S.cerevisiae, homolog 3
, sir2-like 3
, sirtuin type 3
, SIRT3 mitochondrial
, NAD-dependent deacetylase sirtuin-3
, NAD-dependent protein deacetylase sirtuin-3
, SIRT3L mitochondrial
, mitochondrial protein lysine deacetylase
, silent mating type information regulation 2, (S.cerevisiae, homolog)-like 3